These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22290434)

  • 1. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
    Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
    Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
    Vachtenheim J; Novotná H
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
    Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
    Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF
    Smith MP; Rana S; Ferguson J; Rowling EJ; Flaherty KT; Wargo JA; Marais R; Wellbrock C
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):280-291. PubMed ID: 30277012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.
    Choi H; Jin SH; Han MH; Lee J; Ahn S; Seong M; Choi H; Han J; Cho EG; Lee TR; Noh M
    J Dermatol Sci; 2014 Oct; 76(1):60-6. PubMed ID: 25128984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
    He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
    Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf.
    Hornyak TJ; Hayes DJ; Chiu LY; Ziff EB
    Mech Dev; 2001 Mar; 101(1-2):47-59. PubMed ID: 11231058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling.
    Kamaraju AK; Bertolotto C; Chebath J; Revel M
    J Biol Chem; 2002 Apr; 277(17):15132-41. PubMed ID: 11830592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter.
    Galibert MD; Yavuzer U; Dexter TJ; Goding CR
    J Biol Chem; 1999 Sep; 274(38):26894-900. PubMed ID: 10480898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
    Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
    EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
    Medic S; Rizos H; Ziman M
    Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRN2 is a non-canonical melanoma tumor-suppressor.
    Hamm M; Sohier P; Petit V; Raymond JH; Delmas V; Le Coz M; Gesbert F; Kenny C; Aktary Z; Pouteaux M; Rambow F; Sarasin A; Charoenchon N; Bellacosa A; Sanchez-Del-Campo L; Mosteo L; Lauss M; Meijer D; Steingrimsson E; Jönsson GB; Cornell RA; Davidson I; Goding CR; Larue L
    Nat Commun; 2021 Jun; 12(1):3707. PubMed ID: 34140478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
    Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
    Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
    Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
    PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.
    Thurber AE; Douglas G; Sturm EC; Zabierowski SE; Smit DJ; Ramakrishnan SN; Hacker E; Leonard JH; Herlyn M; Sturm RA
    Oncogene; 2011 Jul; 30(27):3036-48. PubMed ID: 21358674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo.
    Pruitt SC; Bussman A; Maslov AY; Natoli TA; Heinaman R
    Gene Expr Patterns; 2004 Oct; 4(6):671-85. PubMed ID: 15465489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 ligase APC/C(Cdh1) promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth.
    Cao J; Dai X; Wan L; Wang H; Zhang J; Goff PS; Sviderskaya EV; Xuan Z; Xu Z; Xu X; Hinds P; Flaherty KT; Faller DV; Goding CR; Wang Y; Wei W; Cui R
    Sci Signal; 2015 Sep; 8(392):ra87. PubMed ID: 26329581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
    Watanabe A; Takeda K; Ploplis B; Tachibana M
    Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro.
    Wang Q; Kumar S; Slevin M; Kumar P
    Cancer Res; 2006 Sep; 66(17):8574-80. PubMed ID: 16951170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
    Zeng H; Jorapur A; Shain AH; Lang UE; Torres R; Zhang Y; McNeal AS; Botton T; Lin J; Donne M; Bastian IN; Yu R; North JP; Pincus L; Ruben BS; Joseph NM; Yeh I; Bastian BC; Judson RL
    Cancer Cell; 2018 Jul; 34(1):56-68.e9. PubMed ID: 29990501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.